Safety and Antitumor Activity of the Multitargeted Pan-TRK, ROS1, and ALK Inhibitor Entrectinib: Combined Results from Two Phase I Trials (ALKA-372-001 and STARTRK-1)
多靶点泛TRK、ROS1和ALK抑制剂恩曲替尼的安全性和抗肿瘤活性:两项I期试验(ALKA-372-001和STARTRK-1)的综合结果
期刊:Cancer Discovery
影响因子:33.3
doi:10.1158/2159-8290.CD-16-1237
Drilon, Alexander; Siena, Salvatore; Ou, Sai-Hong Ignatius; Patel, Manish; Ahn, Myung Ju; Lee, Jeeyun; Bauer, Todd M; Farago, Anna F; Wheler, Jennifer J; Liu, Stephen V; Doebele, Robert; Giannetta, Laura; Cerea, Giulio; Marrapese, Giovanna; Schirru, Michele; Amatu, Alessio; Bencardino, Katia; Palmeri, Laura; Sartore-Bianchi, Andrea; Vanzulli, Angelo; Cresta, Sara; Damian, Silvia; Duca, Matteo; Ardini, Elena; Li, Gang; Christiansen, Jason; Kowalski, Karey; Johnson, Ann D; Patel, Rupal; Luo, David; Chow-Maneval, Edna; Hornby, Zachary; Multani, Pratik S; Shaw, Alice T; De Braud, Filippo G